Form 8-K - Current report:
SEC Accession No. 0001104659-24-113064
Filing Date
2024-10-31
Accepted
2024-10-31 16:15:31
Documents
15
Period of Report
2024-10-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427228d1_8k.htm   iXBRL 8-K 29881
2 EXHIBIT 99.1 tm2427228d1_ex99-1.htm EX-99.1 10014
6 GRAPHIC tm2427228d1_ex99-1img01.jpg GRAPHIC 16677
  Complete submission text file 0001104659-24-113064.txt   241393

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20241031.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20241031_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20241031_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2427228d1_8k_htm.xml XML 3748
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 241415421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)